Print

Lay Description

HYPOTHESIS: Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) have distinct pathophysiologic etiologies. Therefore, therapeutic interventions designed to correct the specific underlying pathogenic abnormalities in IGT and IFG will be required to optimally prevent the progressive beta cell failure and development of overt type 2 diabetes.

Category

  • Diabetes
  • Family Health
  • Obesity
IRB Number
20130414HU
NCT Number
NCT02969798

Eligibility

Eligible Ages
Between 18 Years and 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact

Renata Belfort De Aguiar
210-450-3076
belfortda@uthscsa.edu

Alberto Chavez-Velazquez
210-358-7200
chavezvelazq@uthscsa.edu

Andrea Hansis-Diarte
210-567-3208
hansisdiarte@uthscsa.edu

Aurora Merovci
210-567-6691
merovci@uthscsa.edu

Cynthia Ramirez
210-358-7200
ramirezc8@uthscsa.edu

Principal Investigator
Ralph DeFronzo